Insider Transactions in Q2 2023 at Oak Street Health, Inc. (OSH)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 02
2023
|
Newlight Partners LP Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
32,550,265
-100.0%
|
$1,269,460,335
$39.0 P/Share
|
|
May 02
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
84,482
-100.0%
|
$3,294,798
$39.0 P/Share
|
|
May 02
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,456,206
-100.0%
|
$56,792,034
$39.0 P/Share
|
|
May 02
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
489,270
-100.0%
|
$19,081,530
$39.0 P/Share
|
|
May 02
2023
|
Regina M. Benjamin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,881
-100.0%
|
$931,359
$39.0 P/Share
|
|
May 02
2023
|
Mohit Kaushal Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
215,224
-100.0%
|
$8,393,736
$39.0 P/Share
|
|
May 02
2023
|
Paul B. K. Kusserow Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
480,013
-100.0%
|
$18,720,507
$39.0 P/Share
|
|
May 02
2023
|
Michael T Pykosz Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,040,273
-100.0%
|
$40,570,647
$39.0 P/Share
|
|
May 02
2023
|
Michael T Pykosz Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,126,706
-100.0%
|
$238,941,534
$39.0 P/Share
|
|
May 02
2023
|
Kim Keck Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
94,960
-100.0%
|
$3,703,440
$39.0 P/Share
|
|
May 02
2023
|
Julie D Klapstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,684
-100.0%
|
$1,235,676
$39.0 P/Share
|
|
May 02
2023
|
Griffin Myers Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,845,659
-100.0%
|
$188,980,701
$39.0 P/Share
|
|
May 02
2023
|
Griffin Myers Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,511
-100.0%
|
$331,929
$39.0 P/Share
|
|
May 02
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,080,970
-100.0%
|
$42,157,830
$39.0 P/Share
|
|
May 02
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,879,525
-100.0%
|
$151,301,475
$39.0 P/Share
|
|
May 02
2023
|
Brian Clem Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
569,826
-100.0%
|
$22,223,214
$39.0 P/Share
|
|
May 02
2023
|
Cheryl Dorsey Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
29,484
-100.0%
|
$1,149,876
$39.0 P/Share
|
|
May 02
2023
|
General Atlantic LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
61,384,475
-100.0%
|
$2,393,994,525
$39.0 P/Share
|
|
Apr 26
2023
|
Newlight Partners LP Director |
SELL
Bona fide gift
|
Indirect |
80,000
-100.0%
|
-
|
|
Apr 23
2023
|
Paul B. K. Kusserow Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,140
+1.06%
|
-
|
|
Apr 23
2023
|
Julie D Klapstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,140
+9.17%
|
-
|
|
Apr 23
2023
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,140
+6.48%
|
-
|
|
Apr 23
2023
|
Cheryl Dorsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,140
+14.85%
|
-
|
|
Apr 23
2023
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,140
+2.33%
|
-
|
|
Apr 23
2023
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,140
+17.72%
|
-
|
|
Apr 20
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Other acquisition or disposition
|
Indirect |
1,080,970
+50.0%
|
-
|
|
Apr 20
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Bona fide gift
|
Indirect |
1,080,970
-100.0%
|
-
|
|
Apr 18
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.27%
|
$1,900,000
$38.88 P/Share
|
|
Apr 18
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.26%
|
$1,050,000
$21.0 P/Share
|
|
Apr 10
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,978
-0.41%
|
$227,164
$38.82 P/Share
|
|
Apr 10
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
4,517
-0.12%
|
$171,646
$38.82 P/Share
|
|
Apr 10
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,169
-0.64%
|
$120,422
$38.82 P/Share
|
|
Apr 04
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.27%
|
$1,900,000
$38.8 P/Share
|
|
Apr 04
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.26%
|
$1,050,000
$21.0 P/Share
|